CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health , today announced that following a comprehensive sale process, the U.S. Bankruptcy Court for the Northern District of Texas (the ...

Pumpkinseed founders Jennifer Dionne, Jack Hu, and Nhat Vu discuss their nanophotonic chip platform that promises label-free, ...

Researchers Discover How Tumors Use Peripheral Nerves to Advance Cancer Progression Cancer may be doing far more than growing uncontrollably — it may ...

Daphnia, also known as water fleas, are artists of defense. When their predators live nearby, the water fleas change their ...

The task of gently transporting a microscopic particle from one point to another along a winding path, and then bringing it back using nothing more than a single, compact chip is a challenge we set ...

Three exceptional Simon Fraser University researchers have been named new and renewed Canada Research Chairs. Announced today ...

ChristianaCare has launched a new nonprofit software company to expand its presence in the gene-editing space.

COYA 302, an injection therapy in development for the treatment of ALS, has been awarded fast track status by the U.S. Food and Drug Administration. The therapy aims to slow ALS progression by ...

A 3D network of living neurons and electronics can recognize electrical patterns and may help researchers study both brain ...

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

The world around us is incredibly fantastic and beautiful, no matter how seriously you believe in modern science. Anyway, ...